Multiple Sclerosis Research News -- ScienceDaily //www.koonmotors.com/news/mind_brain/multiple_sclerosis/ Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options. en-us Wed, 06 Sep 2023 14:48:45 EDT Wed, 06 Sep 2023 14:48:45 EDT 60 Multiple Sclerosis Research News -- ScienceDaily //www.koonmotors.com/images/scidaily-logo-rss.png//www.koonmotors.com/news/mind_brain/multiple_sclerosis/ For more science news, visit ScienceDaily. Possible biomarker of MS-like autoimmune disease discovered //www.koonmotors.com/releases/2023/08/230808110850.htm It has been known for several years that the diagnosis 'multiple sclerosis' conceals a whole range of different illnesses, each requiring customized treatment. Researchers have now described a possible new MS-like disease and explained how to diagnose it. Tue, 08 Aug 2023 11:08:50 EDT //www.koonmotors.com/releases/2023/08/230808110850.htm Treatment at the first signs of MS could mean lower risk of disability later //www.koonmotors.com/releases/2023/07/230719221515.htm People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a new study. Wed, 19 Jul 2023 22:15:15 EDT //www.koonmotors.com/releases/2023/07/230719221515.htm Oral medication is the leading choice for multiple sclerosis treatment //www.koonmotors.com/releases/2023/07/230712165200.htm Two injectable therapies accounted for nearly 100 percent of medications for patients in 2001, but by 2020 that decreased to about 25 percent. Wed, 12 Jul 2023 16:52:00 EDT //www.koonmotors.com/releases/2023/07/230712165200.htm Multiple sclerosis: New biomarker confirmed for early diagnosis //www.koonmotors.com/releases/2023/07/230706124618.htm A study has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the procedure helps to detect the condition at an earlier stage and predict its progression more accurately. This can lead to a decisive increase in the chance of improved patient outcomes. Thu, 06 Jul 2023 12:46:18 EDT //www.koonmotors.com/releases/2023/07/230706124618.htm Genetic variant linked with faster progression of multiple sclerosis //www.koonmotors.com/releases/2023/06/230628130340.htm 的研究与多个年代超过22000人clerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability that can rob patients of their mobility and independence over time. Multiple sclerosis begins as an autoimmune disease where the immune system attacks the brain and the spinal cord, resulting in symptom flares, called relapses, as well as longer-term degeneration known as progression. Despite the development of effective treatments for the inflammatory autoimmune disease, none can prevent increased disability during the neurodegenerative phase of the disease. Wed, 28 Jun 2023 13:03:40 EDT //www.koonmotors.com/releases/2023/06/230628130340.htm What makes multiple sclerosis worse, and how to make it better //www.koonmotors.com/releases/2023/06/230628130323.htm Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term disability. Wed, 28 Jun 2023 13:03:23 EDT //www.koonmotors.com/releases/2023/06/230628130323.htm Pregnancy hormone repairs myelin damage in MS mouse model //www.koonmotors.com/releases/2023/06/230615183107.htm A new study has identified a treatment that could repair myelin in the cortex, undoing some of the damage caused by MS. Thu, 15 Jun 2023 18:31:07 EDT //www.koonmotors.com/releases/2023/06/230615183107.htm Can this medication reverse MS? Brain biomarker shows it can //www.koonmotors.com/releases/2023/06/230612200436.htm A decade after scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in repairing the brain, making it possible to also assess future therapies for the devastating disorder. Mon, 12 Jun 2023 20:04:36 EDT //www.koonmotors.com/releases/2023/06/230612200436.htm Children at risk of multiple sclerosis often go undetected in early stages //www.koonmotors.com/releases/2023/03/230316124440.htm Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay treatment of the disease at its earliest stages, according to a new study. Thu, 16 Mar 2023 12:44:40 EDT //www.koonmotors.com/releases/2023/03/230316124440.htm First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases //www.koonmotors.com/releases/2023/03/230308084337.htm A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. Further analysis showed the same gene expression modulation in patients with multiple sclerosis, who experienced decreased brain inflammation, suggesting that Foralumab could be used to treat other diseases. Wed, 08 Mar 2023 08:43:37 EST //www.koonmotors.com/releases/2023/03/230308084337.htm 研究人员发现h又一步ow a brain molecule could halt MS //www.koonmotors.com/releases/2023/02/230201134234.htm A researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. Researchers injected fractalkine into mice with chemically induced MS. They found the treatment increased the number of new oligodendrocytes -- vital brain and spinal cord cells that produce myelin in both embryonic and adult brains -- which are damaged during the MS autoimmune attack. Wed, 01 Feb 2023 13:42:34 EST //www.koonmotors.com/releases/2023/02/230201134234.htm Stem cell transplants may delay disability longer than some MS medications //www.koonmotors.com/releases/2022/12/221221165109.htm In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The study involved autologous hematopoietic stem cell transplants, which use healthy blood stem cells from a person's own body to replace diseased cells. Wed, 21 Dec 2022 16:51:09 EST //www.koonmotors.com/releases/2022/12/221221165109.htm Light therapy relieves fatigue syndrome in Multiple Sclerosis //www.koonmotors.com/releases/2022/12/221212140501.htm Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group identified light therapy as a promising non-drug treatment option: patients included in the study showed a measurable improvement after just 14 days of use. Mon, 12 Dec 2022 14:05:01 EST //www.koonmotors.com/releases/2022/12/221212140501.htm New study identifies connection between diabetes medications, multiple sclerosis //www.koonmotors.com/releases/2022/11/221118144113.htm A study has found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women. Fri, 18 Nov 2022 14:41:13 EST //www.koonmotors.com/releases/2022/11/221118144113.htm Immune system reboot in MS patients //www.koonmotors.com/releases/2022/11/221110101820.htm Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterwards. A better understanding of these mechanisms should help the treatment approach, currently approved in only a few countries, to gain wider acceptance. Thu, 10 Nov 2022 10:18:20 EST //www.koonmotors.com/releases/2022/11/221110101820.htm 研究人员提供路线图确定新的神经细胞oprotective treatments by leveraging sex differences //www.koonmotors.com/releases/2022/11/221104100245.htm Sex differences in the aging brain may offer an enticing clue for developing more effective neuroprotective treatments, according to a new research strategy. Fri, 04 Nov 2022 10:02:45 EDT //www.koonmotors.com/releases/2022/11/221104100245.htm Study advances knowledge of role of brain pathology and cognitive fatigue in multiple sclerosis //www.koonmotors.com/releases/2022/10/221001104312.htm Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for disabling fatigue. Sat, 01 Oct 2022 10:43:12 EDT //www.koonmotors.com/releases/2022/10/221001104312.htm Fish to help in search for MS drugs //www.koonmotors.com/releases/2022/09/220920141424.htm The zebrafish serves as a model organism for researchers around the world: it can be used to study important physiological processes that also take place in a similar form in the human body. It is therefore routinely used in the search for possible active substances against diseases. Researchers have now described an innovative way to do this. In this process, the larvae fish are made a bit more 'human-like'. This humanization could make the search for active pharmaceutical substances much more efficient. Tue, 20 Sep 2022 14:14:24 EDT //www.koonmotors.com/releases/2022/09/220920141424.htm Health care spending may help explain link between multiple sclerosis and latitude //www.koonmotors.com/releases/2022/08/220824170142.htm Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure. But countries farther from the equator are also more likely to be wealthier than countries nearer to the equator. A new analysis shows that the amount a country spends on health care may help explain the link between MS and latitude. Wed, 24 Aug 2022 17:01:42 EDT //www.koonmotors.com/releases/2022/08/220824170142.htm Quality of life with multiple sclerosis may depend on several factors //www.koonmotors.com/releases/2022/08/220810161158.htm Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a person's physical and mental quality of life. Wed, 10 Aug 2022 16:11:58 EDT //www.koonmotors.com/releases/2022/08/220810161158.htm Virtual reality technology could strengthen effects of traditional rehabilitation for multiple sclerosis //www.koonmotors.com/releases/2022/06/220630142201.htm By increasing sensory input and promoting multisensory processing, virtual reality may increase the effectiveness of traditional cognitive rehabilitation and exercise training in individuals with MS, according to researchers. Thu, 30 Jun 2022 14:22:01 EDT //www.koonmotors.com/releases/2022/06/220630142201.htm Harnessing the immune system to treat traumatic brain injury in mice //www.koonmotors.com/releases/2022/05/220526112749.htm 研究人员设计了一个有针对性的治疗treatment that restricts brain inflammation. The effectiveness of this approach in improving outcomes was demonstrated following brain injury, stroke or multiple sclerosis in mice. The system increases the number of regulatory T cells, mediators of the immune system's anti-inflammatory response, in the brain. By boosting the number of T regulatory cells in the brain, the researchers were able to prevent the death of brain tissue in mice following injury and the mice performed better in cognitive tests. The treatment has a high potential for use in patients with traumatic brain injury, with few alternatives currently available to prevent harmful neuroinflammation. Thu, 26 May 2022 11:27:49 EDT //www.koonmotors.com/releases/2022/05/220526112749.htm Uncovering new details of the brain's first line of defense //www.koonmotors.com/releases/2022/05/220520101349.htm A research team has mapped out the development and genetic trajectory of previously understudied macrophages associated with the central nervous system. Among other things, the team found that meningeal macrophages are formed during gestation and develop in the same way as microglia, while perivascular macrophages develop after birth. Their new insights could pave the way for better understanding the origins and mechanisms behind leading brain-related pathologies such as Alzheimer's disease. Fri, 20 May 2022 10:13:49 EDT //www.koonmotors.com/releases/2022/05/220520101349.htm Findings open way for personalized MS treatment //www.koonmotors.com/releases/2022/04/220427140615.htm Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers have now developed a method for identifying the immune cells involved in autoimmune diseases, and have identified four new target molecules of potential significance for future personalized treatment of MS. Wed, 27 Apr 2022 14:06:15 EDT //www.koonmotors.com/releases/2022/04/220427140615.htm A new treatment reduces inflammation in multiple sclerosis mice models //www.koonmotors.com/releases/2022/04/220426101648.htm Researchers managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates inflammation. Tue, 26 Apr 2022 10:16:48 EDT //www.koonmotors.com/releases/2022/04/220426101648.htm Total economic burden of MS in United States is more than $85 billion //www.koonmotors.com/releases/2022/04/220413161815.htm The estimated cost of multiple sclerosis (MS) reached $85.4 billion in 2019 in the United States, according to a new report. In addition, when researchers compared people with MS to people without MS they found that excess medical costs represent 74% of the overall economic burden of MS. The excess medical cost per person was $65,612 that year. Wed, 13 Apr 2022 16:18:15 EDT //www.koonmotors.com/releases/2022/04/220413161815.htm Behavioral treatment for deficits of facial affect recognition in multiple sclerosis //www.koonmotors.com/releases/2022/04/220412141049.htm A recent study has demonstrated efficacy for the behavioral intervention, EMOPRINT, for treating deficits of facial recognition in individuals with multiple sclerosis (MS). The study provides Class I evidence supporting the efficacy of an intervention to treat these deficits in MS. Tue, 12 Apr 2022 14:10:49 EDT //www.koonmotors.com/releases/2022/04/220412141049.htm Researchers develop new antibody test to diagnose multiple sclerosis //www.koonmotors.com/releases/2022/03/220324122612.htm Researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Thu, 24 Mar 2022 12:26:12 EDT //www.koonmotors.com/releases/2022/03/220324122612.htm Research suggests interrupting immune response improves multiple sclerosis outcomes //www.koonmotors.com/releases/2022/03/220322151022.htm Multiple sclerosis is a chronic disease that damages neurons. New research looks at the role that a protein, STAT5, plays in the development of MS. Tue, 22 Mar 2022 15:10:22 EDT //www.koonmotors.com/releases/2022/03/220322151022.htm New discovery may help reduce side effects of multiple sclerosis drugs //www.koonmotors.com/releases/2022/03/220304182954.htm Investigators have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments. Fri, 04 Mar 2022 18:29:54 EST //www.koonmotors.com/releases/2022/03/220304182954.htm Milk may exacerbate MS symptoms //www.koonmotors.com/releases/2022/03/220301131110.htm Multiple sclerosis sufferers often complain of more severe disease symptoms after consuming dairy products. Researchers have now found a possible cause for this. According to the study, a protein in cow's milk can trigger inflammation that targets the 'insulating layer' around nerve cells. The study was able to demonstrate this link in mice, but also found evidence of a similar mechanism in humans. The researchers therefore recommend that certain groups of sufferers avoid dairy products. Tue, 01 Mar 2022 13:11:10 EST //www.koonmotors.com/releases/2022/03/220301131110.htm Myelination determines the nerve cell power of inhibition, study finds //www.koonmotors.com/releases/2022/02/220218100650.htm Researchers shed new light on how myelin loss might underpin aberrant brain activity which have been observed in people with multiple sclerosis. The study suggests that myelination, however patchy on specific interneurons, is required to reach their full inhibitory potential. Fri, 18 Feb 2022 10:06:50 EST //www.koonmotors.com/releases/2022/02/220218100650.htm Multiple sclerosis: Study with twins untangles environmental and genetic influences //www.koonmotors.com/releases/2022/02/220216112303.htm Researchers have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis. In the process, they may have discovered precursor cells of the disease-causing T cells. Wed, 16 Feb 2022 11:23:03 EST //www.koonmotors.com/releases/2022/02/220216112303.htm New genetic clues on multiple sclerosis risk //www.koonmotors.com/releases/2022/01/220128141316.htm An international team of researchers has discovered that a cell type in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) than previously thought. The findings could open for new therapeutical approaches to MS. Fri, 28 Jan 2022 14:13:16 EST //www.koonmotors.com/releases/2022/01/220128141316.htm Meat, MS and the microbiome //www.koonmotors.com/releases/2022/01/220127104246.htm Eating more meat, having less of certain bacteria in the gut, and more of certain immune cells in the blood, all link with multiple sclerosis, reports a team of researchers. The work teased out subtle connections that could lead to a better understanding of the causes of the disease. Thu, 27 Jan 2022 10:42:46 EST //www.koonmotors.com/releases/2022/01/220127104246.htm New MRI technique could improve diagnosis and treatment of multiple sclerosis //www.koonmotors.com/releases/2022/01/220118104107.htm It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible in order to delay progression of the disease. The technique of magnetic resonance imaging (MRI) plays a key role in this process. A new MRI technique could pave the way to quicker assessment of disease activity in MS. Tue, 18 Jan 2022 10:41:07 EST //www.koonmotors.com/releases/2022/01/220118104107.htm Epstein-Barr virus may be leading cause of multiple sclerosis //www.koonmotors.com/releases/2022/01/220113151342.htm A new study provides compelling evidence of causality between Epstein-Barr virus and multiple sclerosis. It suggests that most MS cases could be prevented by stopping EBV infection, and that targeting EBV could lead to the discovery of a cure for MS. Thu, 13 Jan 2022 15:13:42 EST //www.koonmotors.com/releases/2022/01/220113151342.htm Can a human microglial atlas guide brain disorder research? //www.koonmotors.com/releases/2022/01/220106111546.htm Researchers analyzed thousands of microglia from different brain regions of deceased patients who had been diagnosed with a variety of neuropsychiatric and neurodegenerative disorders. Their results support the idea that microglia may play critical roles in some cases of brain disease while also providing a potentially valuable guide for future studies. Thu, 06 Jan 2022 11:15:46 EST //www.koonmotors.com/releases/2022/01/220106111546.htm Scientists identify gut-derived metabolites that play a role in neurodegeneration //www.koonmotors.com/releases/2021/12/211220190638.htm A New York-based, multi-institutional research team has found high levels of three toxic metabolites produced by gut bacteria in the cerebrospinal fluid and plasma samples of multiple sclerosis (MS) patients. The important findings further scientists' understanding of how gut bacteria can impact the course of neurological diseases by producing compounds that are toxic to nerve cells. Mon, 20 Dec 2021 19:06:38 EST //www.koonmotors.com/releases/2021/12/211220190638.htm Sunshine may shield children, young adults from MS //www.koonmotors.com/releases/2021/12/211208161146.htm Living in sunny locations and spending time outdoors may raise the risk for skin cancer, but a new study shows that in children and young adults, sun exposure may protect against multiple sclerosis. The study follows previous work by other researchers that has demonstrated an association between increased ultraviolet exposure in childhood and lower odds of adult MS. Wed, 08 Dec 2021 16:11:46 EST //www.koonmotors.com/releases/2021/12/211208161146.htm In children with multiple sclerosis, teriflunomide tempers lesion growth //www.koonmotors.com/releases/2021/11/211130174008.htm A phase 3 clinical trial tested the safety and efficacy of teriflunomide, an oral immunomodulatory drug, in children with multiple sclerosis. Although the medication did not prevent disease relapses to a greater extent than placebo, the option for some patients to switch from placebo to teriflunomide before the end of the trial likely biased the results against treatment efficacy. The drug appeared to reduce the number of new or enlarged lesions that are detected through MRI. Tue, 30 Nov 2021 17:40:08 EST //www.koonmotors.com/releases/2021/11/211130174008.htm Multiple sclerosis drug improves memory in mice modeling Alzheimer’s disease //www.koonmotors.com/releases/2021/11/211105150501.htm Researchers found that glatiramer acetate, a prescription drug currently used to treat patients with multiple sclerosis, improved memory in a mouse model of Alzheimer's disease. Fri, 05 Nov 2021 15:05:01 EDT //www.koonmotors.com/releases/2021/11/211105150501.htm Vibration training for multiple sclerosis //www.koonmotors.com/releases/2021/11/211104140127.htm Researchers worked to determine whether vibration training -- an intervention used to improve physical function for people with multiple sclerosis -- could also improve patients' cognitive function and quality of life. Thu, 04 Nov 2021 14:01:27 EDT //www.koonmotors.com/releases/2021/11/211104140127.htm Strategies for the regeneration of myelin //www.koonmotors.com/releases/2021/11/211104115248.htm New production or recycling of cholesterol: The duration of the disorder makes all the difference. Thu, 04 Nov 2021 11:52:48 EDT //www.koonmotors.com/releases/2021/11/211104115248.htm A tool to interrogate a new class of drugs //www.koonmotors.com/releases/2021/09/210930082358.htm Reactive electrophilic drugs like Tecfidera, approved for the treatment of relapsing multiple sclerosis, show a lot of potential but are also mystery. Scientists have now used an innovative chemical method to uncover the biological mechanisms of Tecfidera, providing a powerful tool for exploring other reactive electrophilic drugs. Thu, 30 Sep 2021 08:23:58 EDT //www.koonmotors.com/releases/2021/09/210930082358.htm New avenue for study of diseases like multiple sclerosis //www.koonmotors.com/releases/2021/09/210922181518.htm A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination -- when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts communication between nerve cells. Wed, 22 Sep 2021 18:15:18 EDT //www.koonmotors.com/releases/2021/09/210922181518.htm Brain molecule helps 'wake up' cells that could help tackle MS and similar diseases //www.koonmotors.com/releases/2021/09/210909141304.htm An immunological molecule called fractalkine can boost the production of brain cells that produce myelin, a key factor in diseases such as multiple sclerosis, according to recent research. Thu, 09 Sep 2021 14:13:04 EDT //www.koonmotors.com/releases/2021/09/210909141304.htm Cognitive rehabilitation improves cognitive impairment in people with multiple sclerosis //www.koonmotors.com/releases/2021/08/210819195038.htm Experts in MS research suggest that cognitive rehabilitation is an effective approach to improving MS-related cognitive impairment. Thu, 19 Aug 2021 19:50:38 EDT //www.koonmotors.com/releases/2021/08/210819195038.htm Discovery raises possibility of new medication for Alzheimer’s, Parkinson’s //www.koonmotors.com/releases/2021/08/210812092728.htm Researchers have for the first time demonstrated it's possible to use a synthetic thyroid hormone to regulate a gene implicated in neurodegenerative diseases like Alzheimer's, Parkinson's and multiple sclerosis. Thu, 12 Aug 2021 09:27:28 EDT //www.koonmotors.com/releases/2021/08/210812092728.htm A distinctive inflammatory signature found in a genetic form of ALS //www.koonmotors.com/releases/2021/06/210616143159.htm Researchers find an increase in inflammatory molecules in serum and cerebrospinal fluid of C90RF72 patients, informing future anti-inflammatory therapies. Wed, 16 Jun 2021 14:31:59 EDT //www.koonmotors.com/releases/2021/06/210616143159.htm Researchers identify a molecule critical to functional brain rejuvenation //www.koonmotors.com/releases/2021/06/210607084633.htm A new study has identified a molecule called ten-eleven-translocation 1 (TET1) as a necessary component in the repair of myelin, which protects nerves and facilitates accurate transmission of electrical signals. The discovery could have important implications in treating neurodegenerative diseases and for molecular rejuvenation of aging brains in healthy individuals. Mon, 07 Jun 2021 08:46:33 EDT //www.koonmotors.com/releases/2021/06/210607084633.htm Brain disease research reveals differences between sexes //www.koonmotors.com/releases/2021/03/210316112249.htm 科学家强调越来越多的研究ggesting sex differences play roles in how patients respond to brain diseases, as well as multiple sclerosis, motor neuron disease, and other brain ailments. They are urging their colleagues to remember those differences when researching treatments and cures. Tue, 16 Mar 2021 11:22:49 EDT //www.koonmotors.com/releases/2021/03/210316112249.htm Brain's 'wiring insulation' as major factor of age-related brain deterioration //www.koonmotors.com/releases/2021/03/210309185711.htm A new study has identified that one of the major factors of age-related brain deterioration is the loss of a substance called myelin. Myelin acts like the protective and insulating plastic casing around the electrical wires of the brain - called axons. Myelin is essential for superfast communication between nerve cells that lie behind the supercomputer power of the human brain. Tue, 09 Mar 2021 18:57:11 EST //www.koonmotors.com/releases/2021/03/210309185711.htm Mimicking a chronic immune response changes the brain //www.koonmotors.com/releases/2021/02/210217151057.htm Researchers show that simulating an overactive autoimmune response in mice leads to changes in the hippocampal region of the brain. Wed, 17 Feb 2021 15:10:57 EST //www.koonmotors.com/releases/2021/02/210217151057.htm Moms with MS at no more risk of pregnancy complications than moms without MS //www.koonmotors.com/releases/2021/02/210203162305.htm Women with multiple sclerosis (MS) may not be at a higher risk of pregnancy complications like gestational diabetes, emergency cesarean section or stillbirth than women who do not have the disease, according to a new study. Wed, 03 Feb 2021 16:23:05 EST //www.koonmotors.com/releases/2021/02/210203162305.htm Study finds COVID-19 attack on brain, not lungs, triggers severe disease in mice //www.koonmotors.com/releases/2021/01/210119114456.htm Researchers have found that infecting the nasal passages of mice with the virus that causes COVID-19 led to a rapid, escalating attack on the brain that triggered severe illness, even after the lungs were successfully clearing themselves of the virus. Tue, 19 Jan 2021 11:44:56 EST //www.koonmotors.com/releases/2021/01/210119114456.htm Research suggests development of antiviral therapies to treat multiple sclerosis //www.koonmotors.com/releases/2021/01/210115155326.htm Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people. By linking two specific T cells to the loss of myelin, scientists say the new study opens the possibility of developing an antiviral therapy that could be especially useful for newly diagnosed cases of multiple sclerosis. Fri, 15 Jan 2021 15:53:26 EST //www.koonmotors.com/releases/2021/01/210115155326.htm Compound protects myelin, nerve fibers //www.koonmotors.com/releases/2021/01/210113144424.htm A compound appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord. The new research in a mouse model advances earlier work to develop the compound - known as sobetirome - that has already showed promise in stimulating the repair of myelin. Wed, 13 Jan 2021 14:44:24 EST //www.koonmotors.com/releases/2021/01/210113144424.htm Promising MS drug may worsen disease //www.koonmotors.com/releases/2020/11/201113141801.htm The drug has not yet made it to human trials for multiple sclerosis, but scientists are urging their colleagues to move cautiously. Fri, 13 Nov 2020 14:18:01 EST //www.koonmotors.com/releases/2020/11/201113141801.htm Multiple sclerosis as the flip side of immune fitness //www.koonmotors.com/releases/2020/10/201022112554.htm About half of the people with multiple sclerosis have the HLA-DR15 gene variant. A study has now shown how this genetic predisposition contributes to the development of the autoimmune disease multiple sclerosis in combination with environmental factors. The decisive factor is the shaping of a repertoire of immune cells which - although they are effective in fighting off pathogens such as Epstein-Barr virus - also attack brain tissue. Thu, 22 Oct 2020 11:25:54 EDT //www.koonmotors.com/releases/2020/10/201022112554.htm